Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1672460

Corrigendum: RG100204, A Novel Aquaporin-9 Inhibitor, Reduces Septic Cardiomyopathy and Multiple Organ Failure in Murine Sepsis

Provisionally accepted
Shireen MohammadShireen Mohammad1*Caroline E O’RiordanCaroline E O’Riordan2Chiara VerraChiara Verra2Eleonora AimarettiEleonora Aimaretti3Gustavo Ferreira AlvesGustavo Ferreira Alves4Klaus DreischKlaus Dreisch5Johan EvenäsJohan Evenäs5Patrizia GenaPatrizia Gena6Angela TesseAngela Tesse7Michael RutzlerMichael Rutzler8,9Massimo CollinoMassimo Collino4Giuseppe CalamitaGiuseppe Calamita6Christoph ThiemermannChristoph Thiemermann1*
  • 1Queen Mary University of London William Harvey Research Institute, London, United Kingdom
  • 2William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
  • 3Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
  • 4Department of Neurosciences “Rita Levi Montalcini”, University of Turin, Turin, Italy
  • 5Red Glead Discovery, Lund, Sweden
  • 6Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari “Aldo Moro”, Bari, Italy
  • 7Nantes Universite´, Instite National de la Santé et de la Recherche Médicale (INSERM), Centre National de la Rescherche Scientifique (CNRS), l’institut du Thorax, Nantes, France
  • 8Department of Biochemistry and Structural Biology, Lund University, Lund, Sweden
  • 9Apoglyx Akiebolag (AB), Lund, Sweden

This article is a correction to:

  1. RG100204, A Novel Aquaporin-9 Inhibitor, Reduces Septic Cardiomyopathy and Multiple Organ Failure in Murine Sepsis

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Corrigendum on: Mohammad S, O'Riordan CE, Verra C, Aimaretti E, Alves GF, Dreisch K, Evenäs J, Gena P, Tesse A, Rützler M, Collino M, Calamita G andThiemermann C (2022) RG100204, A Novel Aquaporin-9 Inhibitor, Reduces Septic Cardiomyopathy andMultiple Organ Failure in Murine Sepsis. Front. Immunol. 13:900906. doi: 10.3389/fimmu.2022.900906 In the published article, there was an error in Figure 13 as published. The representative images related to Panel A have been inadvertently duplicated in Panel E. The corrected Figure 13 and its caption appear below. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: aquaporin (AQP), Sepsis, cecal ligation and puncture, Inflammation, Multiple Organ Failure

Received: 24 Jul 2025; Accepted: 08 Aug 2025.

Copyright: © 2025 Mohammad, O’Riordan, Verra, Aimaretti, Alves, Dreisch, Evenäs, Gena, Tesse, Rutzler, Collino, Calamita and Thiemermann. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Shireen Mohammad, Queen Mary University of London William Harvey Research Institute, London, United Kingdom
Christoph Thiemermann, Queen Mary University of London William Harvey Research Institute, London, United Kingdom

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material